Obesity and contraceptive use: impact on cardiovascular risk

Obesity and oestrogen containing contraceptive products are well‐known independent cardiovascular risk factors. However, a significant number of obese women continue to receive prescriptions of hormonal products that contain oestrogens for their contraception. We have conducted a narrative review to...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosano, Giuseppe M.C., Rodriguez‐Martinez, Maria Angeles, Spoletini, Ilaria, Regidor, Pedro Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773763/
https://www.ncbi.nlm.nih.gov/pubmed/36103980
http://dx.doi.org/10.1002/ehf2.14104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773763/
https://www.ncbi.nlm.nih.gov/pubmed/36103980
http://dx.doi.org/10.1002/ehf2.14104

Ejemplares similares